Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement

Scuderi, Caterina, Steardo, Luca, Esposito, Giuseppe·2014·Phytotherapy Research
DOI 10.1002/ptr.5095

Cited by (161)

Items 101–161 of 161

  1. Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis
    Albert Stuart Reece, Gary Kenneth Hulse · 2022 · International Journal of Environmental Research and Public Health
  2. Functional interactions between cannabinoids, omega‐3 fatty acids, and peroxisome proliferator‐activated receptors: Implications for mental health pharmacotherapies
    Tony Jung, Roger Hudson, Walter J. Rushlow, Steven R. Laviolette · 2020 · European Journal of Neuroscience
  3. Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions
    Xiao- Bei Zhang, Jintao Li, Juan-Hua Gu, Yue-Qin Zeng · 2021 · Mini-Reviews in Medicinal Chemistry
  4. Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer’s and Parkinson’s Disease
    Rohan V. Gupta, Pravir Kumar · 2021 · ACS Omega
  5. The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology
    Emanuela Aloisio Caruso, Valentina De Nunzio, Valeria Tutino, Maria Notarnicola · 2025 · International Journal of Molecular Sciences
  6. The prevalence, mechanism of action, and toxicity of Nigerian psychoactive plants
    Olamide Wilson Fasakin, Ganiyu Oboh, Ayokunle Olubode Ademosun · 2022 · Comparative Clinical Pathology
  7. The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer’s Disease
    Pei-Pei Guan, Pu Wang · 2023 · Molecular Neurobiology
  8. Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
    Zonghao Hu, Zishun Qin, Jinhong Xie, Yue Qu, Lihua Yin · 2024 · Biomedicine & Pharmacotherapy
  9. PPARα Activation Attenuates Amyloid-β-Dependent Neurodegeneration by Modulating Endo G and AIF Translocation
    Ya-Hsin Cheng, Shih‐Wei Lai, Pei-Yi Chen, Jia‐Hao Chang, Nai Wen Chang · 2014 · Neurotoxicity Research
  10. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cells
    Dylan T. Marsh, Ayato Sugiyama, Yuta Imai, Ryuji Kato, Scott Darryl Smid · 2023 · Basic & Clinical Pharmacology & Toxicology
  11. Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration
    Caterina Ricardi, Anna Mazzierli, Stefano Guglielmo, Nicola Origlia, Francesca Gado, Clementina Manera, Grazia Chiellini, Beatrice Polini · 2025 · International Journal of Molecular Sciences
  12. Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics
    Iman A. Y. Ghannam, Rasha M. Hassan, Mohammed S. Abdel‐Maksoud · 2025 · Bioorganic Chemistry
  13. Fragile X Syndrome: Lessons Learned and What New Treatment Avenues Are on the Horizon
    Randi Jenssen Hagerman, Paul J. Hagerman · 2021 · The Annual Review of Pharmacology and Toxicology
  14. Impact of Cannabis-Based Medicine on Alzheimer’s Disease by Focusing on the Amyloid β-Modifications: A Systematic Study
    Tahereh Farkhondeh, Haroon Zaman Khan, Michael Aschner, Fariborz Samini, Ali Mohammad Pourbagher‐Shahri, Hamed Aramjoo, Babak Roshanravan, Christopher O. Hoyte, Omid Mehrpour, Saeed Samarghandian · 2020 · CNS & Neurological Disorders - Drug Targets
  15. Increasing cannabis use and importance as an environmental contaminant mixture and associated risks to exposed biota: A review
    Emily K. C. Kennedy, Genevieve A. Perono, Dion B. Nemez, Alison C. Holloway, Philippe J. Thomas, Robert James Letcher, Chris H. Märvin, Jörg Stetefeld, Jake M. Stout, Oliver Peters et al. · 2020 · Critical Reviews in Environmental Science and Technology
  16. Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention
    Caterina Scuderi, Lorenzo Golini · 2021 · Animals
  17. Exploring the diversity of cannabis cannabinoid and non-cannabinoid compounds and their roles in Alzheimer's disease: A review
    Hanane Doumar, Hicham El Mostafi, Aboubaker Elhessni, Mohamed Ebn Touhami, Abdelhalem Mesfioui · 2024 · IBRO Neuroscience Reports
  18. The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol
    Bruna Stefane Alves de Oliveira, Debora Sandrini Milanezi, Priscila do Val Gonzaga, Fernanda Rabello Detoni, Renato Nery Soriano · 2022 · Heliyon
  19. A systematic study of molecular targets of cannabidiol in Alzheimer's disease
    Nil Patil, Khushalika Patil, Mukul Jain, Arifullah Mohammed, Alpa Yadav, Parmdeep Singh Dhanda, Chittaranjan Kole, Kirtan Dave, Prashant Kaushik, Mohammad Khairul Azhar Abdul Razab et al. · 2024 · Journal of Alzheimer s Disease Reports
  20. Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide25–35
    Karen del Carmen Barboza Salgado, Rosiene Gomes de Freitas Nascimento, Pedro José Fernandes Nunes Coelho, Laser Antônio Machado Oliveira, Katiane de Oliveira Pinto Coelho Nogueira · 2024 · Toxicology in Vitro
  21. Cannabidiol and Neuroprotection: Evidence from Preclinical Studies
    Nadja Schröder, V.K. da Silva, Jaime E. C. Hallak, Antônio Waldo Zuardi, José Alexandre S. Crippa · 2017 · Elsevier eBooks
  22. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
    Gidion Wilson, Lingling Yang, Xiaojuan Su, Shuqin Ding, Liuyan Li, Youyue Yang, Xiaoying Wang, Weibiao Wang, Yuping Sa, Yue Zhang et al. · 2023 · Pharmacological Reports
  23. Synthetic and Natural Derivatives of Cannabidiol
    Paula Morales, Nadine Jagerovic · 2021 · Advances in experimental medicine and biology
  24. Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration
    Miriam Sciaccaluga, Gabriele Ruffolo, Eleonora Palma, Cinzia Costa · 2023 · Current Neuropharmacology
  25. The Endocannabinoid System and Human Brain Functions
    John C. Ashton, Megan J. Dowie, Michelle Glass · 2017 · Elsevier eBooks
  26. Integrated Mechanism of Lysine 351, PARK2, and STUB1 in AβPP Ubiquitination
    Dhiraj Kumar, Pravir Kumar · 2019 · Journal of Alzheimer s Disease
  27. Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.
    Yasaman Razavi, Fariborz Keyhanfar, Ronak Shabani, Abbas Haghparast, Mehdi Mehdizadeh · 2021 · PubMed Central
  28. Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
    Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D’Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura · 2025 · British Journal of Pharmacology
  29. Combination treatment with medium dose THC and CBD had no therapeutic effect in a transgenic mouse model for Alzheimer's disease but affected other domains including anxiety-related behaviours and object recognition memory
    Beate Aumer, Rossana Rosa Porto, Madilyn Coles, Nina Ulmer, Georgia Watt, Heike Kielstein, Tim Karl · 2025 · Pharmacology Biochemistry and Behavior
  30. Cannabidiolic Acid Rescues Deficits in Hippocampal Long-Term Potentiation in Models of Alzheimer’s Disease: An Electrophysiological and Proteomic Analysis
    Beatriz Gil, Mairéad Sullivan, Caitríona Scaife, Jeffrey Colm Glennon, Caroline E. Herron · 2025 · International Journal of Molecular Sciences
  31. Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APPSwe/PS1∆E9 Mice
    Georgia Watt, Juan C Olaya, Gerald Wolfgang Muench, Brett Garner, Tim Karl · 2026 · Pharmaceuticals
  32. Cannabidiol and Alzheimer Disease: A Comprehensive Review and In Silico Insights Into Molecular Interactions
    João Vitor Mello-Hortega, Carolina Souza-de Oliveira, Vitória Emily Santana De Araújo, Lupe Furtado Alle, Luciane Viater Tureck, Ricardo Lehtonen Rodrigues de Souza · 2025 · European Journal of Neuroscience
  33. Cannabidiol in the treatment and prevention of Alzheimer’s disease – a comprehensive overview of in vitro and in vivo studies
    Paulina Drożak, Urszula Skrobas, Martyna Drożak · 2022 · Journal of Education Health and Sport
  34. Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients
    José Luis Cortes-Altamirano, Ariadna Yáñez-Pizaña, Samuel Reyes-Long, Angélica González-Maciel, Cindy Bandala, Herlinda Bonilla‐Jaime, Alfonso Alfaro-Rodríguez · 2022 · Current Topics in Medicinal Chemistry
  35. Boosting Brain Clean-Up: Can Targeting UPS Genes Offer Neuroprotection?
    Ashi Mannan, Akhil Sharma, Thakur Gurjeet Singh · 2025 · Molecular Neurobiology
  36. The Therapeutic Potential of Synthetic and Natural Cannabinoids in Treating Alzheimer’s Disease
    Nidhi Kanchumarthi, Avigail Rockland, Thejaswini Vembar, Elaine Liu, Rithvik Kanaad, Erick Torres Hinojosa, Kira Tiv, Benjamin Chen, Shira Hao, Sri Guttikonda et al. · 2021 · Berkeley Pharma Tech Journal of Medicine
  37. Effects of Cannabidiol in Adolescent and Young Adult Depressive and Anxiety Disorders: A Systematic Review of Clinical and Preclinical Research
    Rebecca K. Denson, Julia M. Brooks, Graziano Pinna, Natania A. Crane · 2023 · Adolescent Psychiatry
  38. Cannabidiol Pretreatment Reduces Status Epilepticus and Glutamate Uptake Induced by Kainic Acid in Adult Zebrafish
    Karolyne de Pieri Pickler, Ana Caroline Salvador de Farias, Guilherme Lodetti, Henrique Teza Bernardo, Samira Leila Baldin, Eduardo Ronconi Dondossola, Jaime E. C. Hallak, José Alexandre S. Crippa, José Henrique Cararo, Josiane Budni et al. · 2025 · Cannabis and Cannabinoid Research
  39. Cannabidiol and pBDNF Cotreatment Attenuates Pathological Symptoms and Improves Cognition in 3 month-Old 5XFAD Mice
    Bivek Chaulagain, Avinash Gothwal, Arun Kumar Mahanta, Yagna P. R. Jarajapu, Jagdish Singh · 2026 · ACS Chemical Neuroscience
  40. Combining cannabidiol and delta-9-tetrahydrocannabinol at a 50:3 ratio – a new therapeutic strategy for APPSwe/PS1ΔE9 transgenic mice?
    Madilyn Coles, Rossana Rosa Porto, Rose Chesworth, Genevieve Z. Steiner-Lim, Tim Karl · 2026 · Neurobiology of Aging
  41. Phytocannabinoids: a new frontier in Alzheimer’s disease management
    Jagadeesh Sridhara Rao · 2024 · Academia Biology
  42. Endocannabinoid Systetm: Neuropharmacological Implications
    Vivek Sharma, Akshay Chandel, Gunad Acharya, Rahul R Deshmukh · 2015 · Medicine Science | International Medical Journal
  43. Therapeutic potential of cannabidiol and its underlying mechanisms
    Masahito Watanabe, Hana Hayasaki, Yuko Yurugi, Katsuya Watanabe · 2018 · Journal of allied health sciences
  44. Dementia: Alzheimer’s Disease
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  45. Medicinal Cannabis for Alzheimer's Disease
    Genevieve Z. Steiner, Madilyn Coles, Kayla M. Jaye, Najwa‐Joelle Metri, Ali S Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan B. Russo et al. · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  46. Protective Effects of Cannabis in Neuroinflammation-Mediated Alzheimer's Disease
    Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  47. Hemp (Cannabis sativaL.) Agronomic Practices, Engineering Properties, Bioactive Compounds and Utilization in Food Processing Industry
    Vipul Mittal, Anil Panghal, Ravi M. Gupta · 2023 · Wiley eBooks
  48. Medical use of cannabidiol and impact on cancer cell viability
    Wesley M. Raup‐Konsavage, Kent E. Vrana · 2023 · Elsevier eBooks
  49. Modulation of neuroinflammation by natural molecules
    Shashank Kumar Maurya, Rajnikant Mishra · 2024 · Elsevier eBooks
  50. Review, Analyse und Kausalitätsprüfung von Cannabis-based Medicine und Palmitoylethanolamid als Analgetika bei Rheumaschmerzen
    Eliana von Bonin · 2024
  51. Cannabinoids: Adaptogens or Not?
    Federico Karp, Ignácio E. León · 2025 · Cannabis and Cannabinoid Research
  52. Bubble Perfusion Brain Slice Culture with Single-Droplet Stimulus Delivery in a 3D Printed Microfluidic Device
    Genoveve G. Gutierrez, Richard J. Ortiz, Victoria Norman, Rebecca A. Prosser, Christopher A. Baker · 2025 · ACS Measurement Science Au
  53. FIGURES 45. Axinyssa djiferi spec. nov. 4 in A new species of Axinyssa Lendenfeld, 1897 (Porifera, Demospongiae, Halichondrida) from the Senegalese coast
    Nicole Boury‐Esnault, Christian Marschal, Probst, Jean-Michel Korn-, Gilles Barnathan · 2002 · INFM-OAR (INFN Catania)
  54. Cannabidiol–Ion Channel Interactions Represent a Promising Preventive and Therapeutic Strategy in Hepatocellular Carcinoma
    Marí­a de Guadalupe Chávez-López, Arturo Ávalos‐Fuentes, Estrella del C. Cruz-Manzo, Pedro A. Aguirre-Arriaga, Benjamí­n Florán, Julio Isael Pérez‐Carreón, Cecilia Bañuelos, Javier Camacho · 2026 · Pathophysiology
  55. Bioactive Compounds in Mulberry: Their Implications in Health, Disease Prevention, and Food Processing
    Kuruppalli Ramanjappa Mohan, Deepika Halekalyadi Anand, Ravikumar Yelegara Siddappa, Priyanka Bakshi, Paramesha Mahadevappa · 2026 · Current Nutrition & Food Science
  56. Molecular thermodynamic aspects of dissipative structures in oncology, inflammatory and degenerative processes of Central Nervous System diseases
    Alexandre Vallée · 2017 · theses.fr (ABES)
  57. POTENCIAL TERAPÊUTICO DOS FITOCANABINOIDES NA MODULAÇÃO DA NEUROINFLAMAÇÃO EM PATOLOGIAS NEURODEGENERATIVAS
    Jiliélisson Oliveira de Sousa, Charles Fabian de Lima, José Ed Moura de Miranda, Júlia Martins Reis Curvelo Almeida, Maitê Cristina Leite Netto, Fabrizzio German Fernandini Torres, Flávia Carrijo Martins Faria Resendes, Regiane Lourenço Cesar, Alexandre Maslinkiewicz · 2026 · RECIMA21 - Revista Científica Multidisciplinar
  58. Demenz: Alzheimerkrankheit
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  59. Multiple binding modes underlie Cannabis sativa cannabinoids recognition by peroxisome proliferator-activated receptor gamma
    N. R. Carina Alves, Justina Miranda, Lautaro D. Álvarez · 2026 · Frontiers in Bioinformatics
  60. Phytocannabinoid cannabidiol (CBD) in neurodegenerative diseases: From polypharmacology to drug development
    Bingxing Zhang, Jiang Nan, Yunfei Zhang, Boxin Zhang, Changhua Ke, Wen Wang, Teng Wu, Juan Xia, Furong Yang, Meiling He et al. · 2026 · European Journal of Medicinal Chemistry
  61. Cannabidiol in Alzheimer’s disease: evidence-weighted molecular mechanisms and translational challenges
    Sreenivasulu Sura, Saravanan Jagadeesan, Siti Saleha Masrudin, Mohamad Aris Mohd Moklas, Nurul Huda Mohd Nor · 2026 · Molecular Biology Reports